Finepoint Capital »

Revolution Medicines shares owned by Finepoint Capital

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 427k 27.68

More positions owned by Finepoint Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Amicus Therapeutics (FOLD)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS (PRTA)
Galapagos Nv Spon Adr (GLPG)
Ascendis Pharma A/s Sponsored Adr (ASND)
Springworks Therapeutics (SWTX)
Cytokinetics Com New (CYTK)
Cerevel Therapeutics Hldng I (CERE)
Revolution Medicines (RVMD)
ACADIA Pharmaceuticals (ACAD)
Arvinas Ord (ARVN)
Travere Therapeutics (TVTX)
Morphic Hldg (MORF)
Relay Therapeutics (RLAY)

View all positions for Finepoint Capital

Top funds holding Revolution Medicines

Wellington Management Company
Vanguard Group
Nextech Invest
BVF
Casdin Capital
Alphabet
Baker Bros. Advisors
Bellevue Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Boxer Capital
Arch Venture Corp
Deerfield Management Company
Holocene Advisors
Henderson Group

View all funds holding Revolution Medicines